The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Factors affecting the uptake of new medicines: a systematic literature review
Open accessAbstract
BACKGROUND: The successful diffusion of new drugs is crucial for both pharmaceutical companies and patients-and of wider stakeholder concern, including for the funding of healthcare provision. Micro-level characteristics (the socio-demographic and professional characteristics of medical professionals), meso-level characteristics (the prescribing characteristics of doctors, the marketing efforts of pharmaceutical companies, interpersonal communication among doctors, drug attributes, and the characteristics of patients), and macro-level characteristics (government policies) all influence the diffusion of new drugs. This systematic literature review examines the micro- and meso-level characteristics of early prescribers of newly introduced drugs. Understanding the characteristics of early adopters may help to speed up the diffusion process, promote cost-efficient prescribing habits, forecast utilisation, and develop targeted intervention strategies. METHODS: The PubMed and Scopus electronic databases were chosen for their extensive coverage of the pertinent literature and used to identify 205 potentially relevant studies by means of a four-layered search string. The 35 studies deemed eligible were then synthetized carefully and critically, to extract variables relevant to this review. RESULTS: Early adoption of new drugs is not a personal trait, independent of drug type, but early adopters share both micro- and meso-level characteristics. At prescriber level, doctors' interest in particular therapeutic areas, participation in clinical trials, and volume of prescribing-either in total or within the therapeutic class of the new drug-increase the likelihood of early adoption. The marketing efforts of pharmaceutical companies and doctors' professional and social interactions leading to prescribing contagion are very powerful predictors of new drug uptake. At patient level, doctors with younger patients, patients with higher socioeconomic statuses and/or patients with poorer health statuses are more inclined to prescribe new drugs early. In contrast, the socio-demographic characteristics of prescribers and many practice-related factors play little role in the adoption process. CONCLUSIONS: The most powerful predictors of new drug uptake include the doctors' strong scientific commitment, high prescribing volume in total or in within the therapeutic class of the new drug, high exposure to marketing, and intense communication with colleagues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opinion Leadership and Social Contagion in New Product Diffusion
Iyengar, R., Van den Bulte, C., & Valente, T. W. (2011) · Marketing Science · doi:10.1287/mksc.1100.0566 · Cited by 996
Dybdahl, T., Andersen, M., S�ndergaard, J., Kragstrup, J., & Kristiansen, I. S. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0797-1 · Cited by 31
Cited by
DeJong, C., Aguilar, T., Tseng, C.-W., Lin, G. A., Boscardin, W. J., & Dudley, R. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2765 · Cited by 517
Socioeconomic aspects of incretin-based therapy
Karagiannis, T., Bekiari, E., & Tsapas, A. (2023) · Diabetologia · doi:10.1007/s00125-023-05962-z · Cited by 91
Cromer, S. J., Lauffenburger, J. C., Levin, R., & Patorno, E. (2023) · Diabetes Care · doi:10.2337/dc22-0383 · Cited by 36
Thomas, D. D., Waring, M. E., Ameli, O., Reisman, J. I., & Vimalananda, V. G. (2019) · Obesity · doi:10.1002/oby.22503 · Cited by 25
Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
Zhai, M. Z., Avorn, J., Liu, J., & Kesselheim, A. S. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.40117 · Cited by 7
Metadata
- Authors
- Lublóy, Á.
- Venue
- BMC Health Services Research
- Published
- 2014-10-20
- Volume
- 14
- Issue
- 1
- Pages
- 469-469
- ISSN
- 1472-6963 (ISSN-L)
- OpenAlex
- W1972238898
- Cited by
- 211
- References
- 2
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors affecting the uptake of new medicines: a systematic literature review. https://app.cochat.ai/papers/10.1186/1472-6963-14-469
- The paper
- Lublóy, Á. (2014). Factors affecting the uptake of new medicines: a systematic literature review. BMC Health Services Research. https://doi.org/10.1186/1472-6963-14-469
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.